Lifshitz & Miller Law Firm Announces Investigation of Cempra, Inc., Commvault Systems, Inc., Dakota Plains Holdings, Inc., Diplomat Pharmacy, Inc., Dynavax Technologies Corporation, Endologix, Inc., OneMain Holdings, Inc. and StoneMor Partners L.P.
NEW YORK, Dec.1, 2016 /PRNewswire/ --
Commvault Systems, Inc. (CVLT)
Lifshitz & Miller announces investigation on behalf of CVLT investors. The investigation concerns whether CVLT violated federal securities laws by issuing false and misleading statements concerning CVLT deferring revenue recognition to create the illusion of growth.
If you are a CVLT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Dakota Plains Holdings, Inc. (DAKP)
Lifshitz & Miller announces investigation on behalf of DAKP investors. The investigation concerns whether DAKP violated federal securities laws by issuing false and misleading financial statements in connection with an alleged stock manipulation scheme by DAKP's co-founders.
If you are a DAKP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Diplomat Pharmacy, Inc. (DPLO)
Lifshitz & Miller announces investigation on behalf of DPLO investors. The investigation concerns whether DPLO violated federal securities laws by issuing false and misleading statements concerning its calculation of DIR fees and performance of DPLO's hepatitis C segment.
If you are a DPLO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Dynavax Technologies Corporation (DVAX)
Lifshitz & Miller announces investigation on behalf of DVAX investors concerning whether DVAX adequately disclosed DVAX's phase 3 trial for lead vaccine product HEPLISAV-B.
If you are a DVAX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Endologix, Inc. (ELGX)
Lifshitz & Miller announces investigation on behalf of ELGX investors. The investigation concerns whether ELGX violated federal securities laws by issuing false and misleading statements concerning the Nellix investigational device exemption clinical trial.
If you are a ELGX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
OneMain Holdings, Inc. (OMF)
Lifshitz & Miller announces investigation on behalf of OMF investors. The investigation concerns whether OMF violated federal securities laws by issuing false and misleading statements concerning its financial results after OMF lowered its guidance for 2016 and 2017.
If you are an OMF investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
StoneMor Partners L.P. (STON)
Lifshitz & Miller announces investigation on behalf of STON investors. The investigation concerns whether STON violated federal securities laws by issuing false and misleading statements concerning STON's debt and equity offerings and distributions to unitholders.
If you are a STON investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]
SOURCE Lifshitz & Miller Law Firm
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article